Cargando…

Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4.

In the adoptive immunotherapy for cancer, the amounts of induced effector cells play a major role in improving therapeutic efficacy. We have already demonstrated that interleukin 4 (IL-4) augments proliferation of tumour-infiltrating lymphocytes (TILs) without altering the cytotoxic activity against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsunoda, T., Tanimura, H., Yamaue, H., Iwahashi, M., Tani, M., Noguchi, K., Hotta, T., Mizobata, S., Arii, K.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077114/ https://www.ncbi.nlm.nih.gov/pubmed/8855979

Ejemplares similares

Fibronectin promotes the proliferation of cytotoxic T lymphocytes generated from cancer patients.
por: Mizobata, S., et al.
Publicado: (1996)

Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay.
por: Yamaue, H., et al.
Publicado: (1992)

Antitumor Effects of Interleukin‐2 Gene‐modified Fibroblasts in an Orthotopic Colon Cancer Model
por: Terasawa, Hiroshi, et al.
Publicado: (1999)

Specific T-cell immunity against Ki-ras peptides in patients with pancreatic and colorectal cancers
por: Shono, Y, et al.
Publicado: (2003)

Inhibition of IL-17A in Tumor Microenvironment Augments Cytotoxicity of Tumor-Infiltrating Lymphocytes in Tumor-Bearing Mice
por: Hayata, Keiji, et al.
Publicado: (2013)

Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas
por: Tanaka, H, et al.
Publicado: (2001)

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53
por: Umano, Y, et al.
Publicado: (2001)

Dose of Adenoviral Vectors Expressing Interleukin‐2 Plays an Important Role in Combined Gene Therapy with Cytosine Deaminase/5–Fluorocytosine: Preclinical Consideration
por: Nakamori, Mikihito, et al.
Publicado: (2002)

BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes
por: Cooper, Zachary A, et al.
Publicado: (2013)

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes
por: Sittig, Simone P, et al.
Publicado: (2013)

Interleukin‐12 Augments the Generation of Autologous Tumor‐reactive CD8(+) Cytotoxic T Lymphocytes from Tumor‐infiltrating Lymphocytes
por: Kuge, Soichi, et al.
Publicado: (1995)

Tumor-infiltrating T lymphocyte clonality predicts prognosis in human ovarian cancer
por: Tsuji, Takemasa, et al.
Publicado: (2013)

Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo
por: Hazama, S, et al.
Publicado: (1999)

Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
por: Ward, M J, et al.
Publicado: (2014)

Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.
por: Yoong, K. F., et al.
Publicado: (1998)

On the clonality of tumours.
por: Woodruff, M. F., et al.
Publicado: (1985)

Matrix Metalloproteinases in Cytotoxic Lymphocytes Impact on Tumour Infiltration and Immunomodulation
por: Edsparr, Karin, et al.
Publicado: (2010)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
por: Lee, H E, et al.
Publicado: (2008)

Validation of multiplex immunofluorescence for use in analysis of tumour infiltrating lymphocytes
por: Galetta, Henry, et al.
Publicado: (2015)

Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
por: Naghavian, Reza, et al.
Publicado: (2023)

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2
por: De Paola, F, et al.
Publicado: (2003)

Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
por: Noble, Fergus, et al.
Publicado: (2016)

S47. Tumour infiltrating lymphocytes - a predictive marker?
por: Galon, J
Publicado: (2014)

Tumour-infiltrating lymphocytes: from prognosis to treatment selection
por: Brummel, Koen, et al.
Publicado: (2022)

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.
por: Whitford, P., et al.
Publicado: (1990)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
por: Gooden, M J M, et al.
Publicado: (2011)

Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis.
por: Adams, D. H., et al.
Publicado: (1997)

Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model
por: Satooka, Hiroki, et al.
Publicado: (2020)

T-cell receptor gene expression in tumour-infiltrating lymphocytes and peripheral blood lymphocytes of patients with nasopharyngeal carcinoma.
por: Chen, Y., et al.
Publicado: (1995)

Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancer
por: Robertson, Jane, et al.
Publicado: (2019)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

Functional role of IL-2 receptors on tumour-infiltrating lymphocytes.
por: Trentin, L., et al.
Publicado: (1994)

Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma
por: Maddison, Kelsey, et al.
Publicado: (2021)

Tumour-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumour and nodal stage
por: Glaire, Mark A., et al.
Publicado: (2019)

Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia
por: Yeh, Paul, et al.
Publicado: (2017)

The adequacy of tissue microarrays in the assessment of inter- and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcoma
por: Lee, A. T. J., et al.
Publicado: (2019)

Tumour-infiltrating lymphocytes in the risk stratification of squamous cell carcinoma of the head and neck
por: Jones, T M
Publicado: (2014)

Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_6m0vs328idopghu185cnaj9vd9